Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Publishing timestamp: 2023-02-17 15:25:35
Summary
A group of 20 senators called on Medicare to offer broad coverage of Alzheimer's treatments approved by the FDA, warning that current restrictions cost patients precious time as their disease progresses. The maker of a promising Alzheimer's drug, Leqembi, expects full FDA approval this summer, which would expand Medicare coverage.
Sentiment: POSITIVE
Tickers: BIIB, 4523.T-JP, ESALY,
Keywords: coronavirus, eisai co ltd, politics, pandemics, u.s. economy, health care industry, business, biogen inc, biotechnology, business news, biotech and pharmaceuticals, breaking news: business, disease outbreaks, epidemics, united states,
Source: https://www.cnbc.com/2023/02/17/senators-urge-medicare-to-cover-alzheimers-treatments.html